CHILDS NERVOUS SYSTEM, vol.24, no.3, pp.289-292, 2008 (SCI-Expanded)
Background After the achieved high cure rates, the survivors of medulloblastoma have come to face other complications associated with treatment regimes. One of these complications is secondary malignant neoplasm (SMN), which is rare but generally fatal.